Last reviewed · How we verify
Adjuvant tamoxifen + goserelin (premenopausal women) (adjuvant-tamoxifen-goserelin-premenopausal-women)
Adjuvant tamoxifen + goserelin (premenopausal women) (generic name: adjuvant-tamoxifen-goserelin-premenopausal-women) is a drug developed by Pfizer Inc.. It is currently in Phase 2 development.
At a glance
| Generic name | adjuvant-tamoxifen-goserelin-premenopausal-women |
|---|---|
| Sponsor | Pfizer Inc. |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial (PHASE2)
- Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea (PHASE3)
- Evaluating the Role of the Addition of Ovarian Function Suppression (OFS) to Tamoxifen in Young Women (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Adjuvant tamoxifen + goserelin (premenopausal women) CI brief — competitive landscape report
- Adjuvant tamoxifen + goserelin (premenopausal women) updates RSS · CI watch RSS
- Pfizer Inc. portfolio CI
Frequently asked questions about Adjuvant tamoxifen + goserelin (premenopausal women)
What is Adjuvant tamoxifen + goserelin (premenopausal women)?
Adjuvant tamoxifen + goserelin (premenopausal women) (adjuvant-tamoxifen-goserelin-premenopausal-women) is a pharmaceutical drug developed by Pfizer Inc..
Who makes Adjuvant tamoxifen + goserelin (premenopausal women)?
Adjuvant tamoxifen + goserelin (premenopausal women) is developed by Pfizer Inc. (see full Pfizer Inc. pipeline at /company/pfizer).
What is the generic name of Adjuvant tamoxifen + goserelin (premenopausal women)?
adjuvant-tamoxifen-goserelin-premenopausal-women is the generic (nonproprietary) name of Adjuvant tamoxifen + goserelin (premenopausal women).
What development phase is Adjuvant tamoxifen + goserelin (premenopausal women) in?
Adjuvant tamoxifen + goserelin (premenopausal women) is in Phase 2.
Related
- Manufacturer: Pfizer Inc. — full pipeline